Clinical, laboratory and functional determinants of symptoms and exercise capacity in hypertrophic cardiomyopathy

12 May 2024 (10:00 - 10:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Michal Tkaczyszyn

Wroclaw Medical University, Wroclaw (Poland)

6 More presentations in this session

Presentation thumbnail

Factors of long-COVID symptoms 15-months post-recovery

Mrs K. Gryglewska-Wawrzak (Lodz, PL)

Abstract Slides Video

Presentation thumbnail

Sex-related disparities in the diagnosis of transthyretin cardiac amyloidosis (ATTR-CA) using technetium-pyrophosphate imaging (Tc-PYP)

Miss S. Babbar (Toronto, CA)

Abstract Slides Video

Presentation thumbnail

Factors associated with changes in fatigue in patients with heart failure

Professor T. Jaarsma (Linkoping, SE)

Abstract Slides Video

Presentation thumbnail

Subclinical congestion at discharge at patients admitted with acute decompensation of heart failure

Doctor M. Stratinaki (Heraklion, GR)

Abstract Slides Video

Presentation thumbnail

Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: initial characteristics of the population, design and rationale of the ARCHER trial

Doctor C. Tschoepe (Berlin, DE)

Abstract Slides

Access the full session

Session thumbnail

Chronic heart failure 2

The Event

Event poster

Heart Failure 2024

12 May 2024 10:00 CET

You may be interested in

Congress Presentation

Skeletal and respiratory muscle weakness contributes to decreased exercise capacity in hypertrophic cardiomyopathy

Congress Presentation

Cardiopulmonary exercise test predicts long-term prognosis in asymptomatic patients with hypertrophic cardiomyopathy

Congress Presentation

Cardiopulmonary exercise testing in paediatric hypertrophic cardiomyopathy: functional profiles and prognostic value

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources